Početna › Veliki depresivni poremećaj › Arizona
Kliničke studije za Veliki depresivni poremećaj u državi Arizona
13 studija za Veliki depresivni poremećaj traži sudionike na lokacijama u državi Arizona.
Gradovi u državi Arizona
Službeni tekst studije (engleski)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- NoesisPharma, LLC, Phoenix
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07775300Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- University of Arizona, Tucson
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- IMA Clinical Research- Phoenix, Phoenix
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07621237A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Lighthouse Psychiatry, Gilbert
U tijeku regrutacijaFaza 3
Od 18 do 85 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Phoenix
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06830044Lumateperone for Late-Life Depression
- University of Arizona, Tucson
U tijeku regrutacijaFaza 3
Od 60 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07623135A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Phoenix
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07610473A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- IMA Clinical Research Phoenix, Phoenix
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06775379A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- NoesisPharma, LLC, Phoenix
- Del Sol Research Management, Tucson
U tijeku regrutacijaFaza 2
Od 18 do 64 godina · Oba spola · Ažurirano 27. srp 2026. · NCT07115329Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Tucson
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 24. srp 2026. · NCT07484217A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Ima Clinical Research Phoenix (Alea) /ID# 277516, Phoenix
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 15. lip 2026. · NCT07276997A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Noble Clinical Research, Tucson
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 11. svi 2026. · NCT06524830Study of ALTO-300 in MDD
- Site 200, Phoenix
- Site 187, Yuma
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 24. srp 2025. · NCT05922878Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.